Middleway Nutrition
Evidence-based GLP-1 and peptide science.
Clear clinical research, dosing context, safety tradeoffs, and practical guides organized into two focused archives.
Latest Articles
20 articles
GLP-1 and GIP: How Two Gut Hormones Drive the Most Effective Weight-Loss Drugs
GLP-1 gets the headlines, but it is the addition of GIP that makes tirzepatide outperform semaglutide. The mechanism is surprising — and tirzepatide actually binds GLP-1 weaker than the hormone it mimics.
GLP-1GLP-1 Before and After: Month-by-Month Weight Loss Timeline (Real Data)
Trials show 15–22% mean weight loss over 18 months on a GLP-1. Real-world data is much lower — about 2% at 72 weeks on older drugs at standard doses. Here is the full curve and what drives the gap.
GLP-1GLP-1 Reviews 2026: What Real Patients Rate Zepbound, Wegovy, Ozempic, and Mounjaro
Aggregated patient reviews across Drugs.com and WebMD: Zepbound 8.7/10, Mounjaro 8.4/10, Wegovy 7.4/10, Ozempic 6.7/10. What people love, what they hate, and why fewer than 1 in 4 stay on past a year.
GLP-1GLP-1 Supplements: Drops, Gummies, and Boosters — What's In Them, What They Cost, What They Do
Injectable semaglutide raises GLP-1 by over 1,000%. The best OTC supplement gummies raise it by ~17%. Here's the brand-by-brand breakdown — ingredients, prices, evidence, and what they're really worth.
GLP-1GLP-1 Benefits for Women: PCOS, Menopause, Fertility, and What's Different in 2026
Women lose more total weight than men on GLP-1s on average but progress slightly slower per dose. The drugs normalize cycles in ~80% of PCOS responders, drive an Ozempic baby boom in once-infertile women, and reduce breast cancer risk signals — while raising bone density and hair loss concerns unique to female biology.
GLP-1GLP-1 and Kidney Disease: FLOW Trial Data and Ozempic's FDA-Approved CKD Indication
FDA approved Ozempic (semaglutide) on January 28, 2025 to slow kidney disease progression in adults with type 2 diabetes and CKD. The FLOW trial in 3,533 patients showed a 24% reduction in major kidney events — independent of weight loss.
GLP-1How to Boost GLP-1 Naturally: Foods, Exercise, and Habits That Actually Work
Your body makes GLP-1 every time you eat — but DPP-4 destroys it within 1-2 minutes. Protein, soluble fiber, healthy fats, fermented foods, and exercise amplify the pulse. Here's the evidence-based playbook.
GLP-1GLP-1 for Heart Failure: STEP-HFpEF, SUMMIT, and Why HFpEF Is Where the Data Lives
Semaglutide and tirzepatide both improve symptoms in obesity-related HFpEF. STEP-HFpEF: +7.8 KCCQ points, -13.3% weight. SUMMIT: 38% lower risk of CV death or worsening heart failure with tirzepatide.
GLP-1GLP-1 Face (Ozempic Face): Mechanism, Prevention, and What Actually Treats It
Dermatologist Dr. Paul Jarrod Frank coined the term in 2022. Beyond rapid weight loss, new research shows GLP-1 receptors directly affect adipose stem cells, fibroblasts, and collagen synthesis — explaining why the face ages faster than the rest of the body.
GLP-1GLP-1 Recipes: 15 High-Protein Meals That Won't Trigger Nausea (2026)
Fifteen specific GLP-1-friendly recipes with exact ingredients, protein grams, calorie counts, and gentle cooking methods. Plus a sample 100g protein day and a list of dishes to avoid because of GI side effects.
GLP-1GLP-1 Lawsuits 2026: Where MDL-3094 and MDL-3163 Stand Today
More than 3,600 federal lawsuits allege gastroparesis, NAION blindness, and other injuries from GLP-1 drugs. Bellwether trials are expected mid-2026. Here is the full status.
GLP-1GLP-1 Online: The 9 Telehealth Providers Worth Knowing in 2026
The compounded free-for-all is over. After the FDA cleared the shortage list and sent 55+ warning letters, GLP-1 telehealth split into branded-only and compounded-503A camps. Here is each major provider's real pricing, medication list, and trade-offs.
GLP-1GLP-1 vs GLP-2: Same Gene, Two Completely Different Drug Classes
GLP-1 and GLP-2 come from the same proglucagon gene and are released by the same intestinal cells — but they hit different receptors, do different jobs, and treat completely different diseases. One is the basis of Ozempic. The other is the basis of a $300,000-a-year drug for short bowel syndrome.
GLP-1GLP-1 Near Me: How to Find a Local Prescriber in 2026
Four local paths to a GLP-1 prescription — primary care, obesity medicine clinics, retail clinics like MinuteClinic, and med spas. What each charges, what they include, and how to vet.
GLP-1GLP-1 for Fatty Liver: Wegovy's August 2025 MASH Approval, ESSENCE Trial Data, and How Semaglutide, Tirzepatide, and Retatrutide Compare
FDA approved Wegovy (semaglutide) on August 15, 2025 as the first GLP-1 for MASH with moderate-to-advanced fibrosis. ESSENCE trial: 62.9% steatohepatitis resolution vs 34.3% placebo, 36.8% fibrosis improvement vs 22.4%.
GLP-1Which GLP-1 Is Best for Weight Loss? The 2026 Decision Matrix
Tirzepatide produces the most pure weight loss of any approved GLP-1 — 20.9% in SURMOUNT-1 and 20.2% vs semaglutide's 13.7% in the head-to-head SURMOUNT-5. But \"best\" depends on whether your goal is maximum loss, cardiovascular protection, kidney protection, OSA, no needles, or lowest cost.
GLP-1GLP-1 Injection Sites: Abdomen, Thigh, or Arm — and Why Rotation Matters
All three FDA-approved sites work, but absorption from the thigh is about 12% lower than the abdomen. The bigger issue is rotation — up to two-thirds of users develop lipohypertrophy without it.
GLP-1GLP-1 Long Term Side Effects: 5+ Years of Trial and Real-World Data
Most GLP-1 side effects fade after 3-6 months. What persists matters more — muscle loss in 25-40% of weight lost without strength training, gallbladder disease at 2x rate, and the NAION signal for semaglutide.
GLP-1GLP-1 Benefits Beyond Weight Loss: 13 Conditions With Real Evidence in 2026
GLP-1 drugs are FDA approved for diabetes, cardiovascular disease, kidney disease, sleep apnea, and MASH. Active research covers Alzheimer's, addiction, COVID, fertility, cancer, asthma, and arthritis. Here is the evidence.
GLP-1GLP-1 Contraindications: The Complete Absolute and Relative List (2026)
Some conditions absolutely rule out GLP-1 medications. Others require caution and monitoring. Here is every contraindication for semaglutide and tirzepatide — and the conditions people wrongly think disqualify them.